Cargando…
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Tumour cells exploit both genetic and adaptive means to survive and proliferate in hypoxic microenvironments, resulting in the outgrowth of more aggressive tumour cell clones. Direct measurements of tumour oxygenation, and surrogate markers of the hypoxic response in tumours (for instance, hypoxia i...
Autores principales: | Jubb, Adrian M, Buffa, Francesca M, Harris, Adrian L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837600/ https://www.ncbi.nlm.nih.gov/pubmed/19840191 http://dx.doi.org/10.1111/j.1582-4934.2009.00944.x |
Ejemplares similares
-
Gene expression and hypoxia in breast cancer
por: Favaro, Elena, et al.
Publicado: (2011) -
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
por: Abu-Jamous, Basel, et al.
Publicado: (2017) -
Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth
por: Oon, Chern Ein, et al.
Publicado: (2017) -
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
por: Haider, Syed, et al.
Publicado: (2016) -
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
por: Dhawan, Andrew, et al.
Publicado: (2018)